Cargando…
Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
Long-term nucleos(t)ide analogue therapy in chronic hepatitis B virus (HBV) infection is effective in suppressing viral replication and reducing liver-related complications. However, HBV-related liver events can still occur in different patient sub-groups. There is emerging evidence that, similar to...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343097/ https://www.ncbi.nlm.nih.gov/pubmed/30686897 http://dx.doi.org/10.3748/wjg.v25.i3.282 |